Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010

The US Public Health Emergency Medical Countermeasures Enterprise convened subject matter experts at the 2010 HHS Burkholderia Workshop to develop consensus recommendations for postexposure prophylaxis against and treatment for Burkholderia pseudomallei and B. mallei infections, which cause melioido...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 18; no. 12; p. e2
Main Authors Lipsitz, Rebecca, Garges, Susan, Aurigemma, Rosemarie, Baccam, Prasith, Blaney, David D, Cheng, Allen C, Currie, Bart J, Dance, David, Gee, Jay E, Larsen, Joseph, Limmathurotsakul, Direk, Morrow, Meredith G, Norton, Robert, O'Mara, Elizabeth, Peacock, Sharon J, Pesik, Nicki, Rogers, L Paige, Schweizer, Herbert P, Steinmetz, Ivo, Tan, Gladys, Tan, Patrick, Wiersinga, W Joost, Wuthiekanun, Vanaporn, Smith, Theresa L
Format Journal Article Conference Proceeding
LanguageEnglish
Published United States Centers for Disease Control and Prevention 01.12.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The US Public Health Emergency Medical Countermeasures Enterprise convened subject matter experts at the 2010 HHS Burkholderia Workshop to develop consensus recommendations for postexposure prophylaxis against and treatment for Burkholderia pseudomallei and B. mallei infections, which cause melioidosis and glanders, respectively. Drugs recommended by consensus of the participants are ceftazidime or meropenem for initial intensive therapy, and trimethoprim/sulfamethoxazole or amoxicillin/clavulanic acid for eradication therapy. For postexposure prophylaxis, recommended drugs are trimethoprim/sulfamethoxazole or co-amoxiclav. To improve the timely diagnosis of melioidosis and glanders, further development and wide distribution of rapid diagnostic assays were also recommended. Standardized animal models and B. pseudomallei strains are needed for further development of therapeutic options. Training for laboratory technicians and physicians would facilitate better diagnosis and treatment options.
Bibliography:ObjectType-Article-1
ObjectType-Feature-2
content type line 25
ObjectType-News-3
SourceType-Conference Papers & Proceedings-1
ObjectType-Conference-4
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1812.120638